Clinical trials recruiting in Hod HaSharon, Israel

Phase breakdown

Conditions recruiting in Hod HaSharon, Israel

Recruiting trials in Hod HaSharon, Israel

• A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
  NCT02332668 · Phase: Phase 1, Phase 2 · Ages: 6 Months to 17 Years · Sex: All (male and female)
• A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
  NCT06929273 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
  NCT07140913 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
  NCT06951711 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Stratification and Treatment in Early Psychosis Study - ENHANCE
  NCT06778564 · Phase: Phase 3 · Ages: 16 Years to 40 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Hod HaSharon, Israel?

5 recruiting trials have at least one study site in Hod HaSharon, Israel.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.